Bert Blyleven: let the PED users in the Hall of Fame


I wrote yesterday about how I reconcile PED use and the Hall of Fame.  I’ve written a lot about Bert Blyleven and the Hall of Fame. Say, how can those things go together?

Via the Jonah Keri Podcast, of course.  Jonah has been talking to some serious heavyweights this week, and the other day Blyleven gave Jonah a half hour of his time.  It’s all worth listening to, but I think the most interesting part is when they talk about steroid users and the Hall. Blyleven’s take? Let McGwire, Bonds and Clemens in. His rationale (more or less) is that a lot of guys were taking and they all didn’t become Hall of Famers, so why degrade the accomplishments of the ones who did? This is a rough approximation of my own stance: sure, guys used PEDs, but it’s not like that prevents us from distinguishing them from other players and recognizing their greatness. At least if we don’t take a blanket “no PED users in the Hall” approach.  Which I think is extremely problematic.

Not that Blyleven and I agree on everything.  He would change his mind on Bonds or Clemens if they were to be convicted in their respective criminal prosecutions. Hard to say if he thinks that’s because that would officially make them criminals and thus disqualify them on moral grounds or, alternatively, if it would merely remove some extant doubt from his mind about what they did while they played.  Bert is also part of the “release all the names” club which, as I have argued is simply wrong.

But however he comes down, it’s a good interview and a good window on how hard it is to figure out what to do with the Hall of Fame in the wake of the steroid era.

Report: Athletics sign Trevor Cahill to one-year deal

Getty Images
1 Comment

Free agent right-hander Trevor Cahill reportedly has a one-year deal in place with the Athletics, according to’s Jane Lee. The exact terms have yet to be disclosed, and as the agreement is still pending a physical, it has not been formally announced by the club.

Cahill, 30, is coming off of a decent, albeit underwhelming year with the Padres and Royals. He kicked off the 2017 season with a 4-3 record in 11 starts for the Padres, then split his time between the rotation and bullpen after a midseason trade to the Royals. By the end of the year, the righty led the league with 16 wild pitches and had racked up a 4.93 ERA, 4.8 BB/9 and 9.3 SO/9 in 84 innings for the two teams.

The A’s found themselves in desperate need of rotation depth this week after Jharel Cotton announced he’d miss the 2018 season to undergo Tommy John surgery. Right now, the team is considering some combination of Andrew Triggs, Daniel Gossett, Daniel Mengden and Paul Blackburn for the back end of the rotation — a mix that seems unlikely to change in the last two weeks before Opening Day, as Lee points out that Cahill won’t be ready to shoulder a full workload by then. Instead, he’s expected to begin the year in the bullpen and work his way up to a starting role, where the A’s hope he’ll replicate the All-Star numbers he produced with them back in 2010.